Shareholders who lost money in shares of DexCom, Inc. (NASDAQ: DXCM) Should Contact Wolf Haldenstein Immediately

Lead Plaintiff Deadline is December 26, 2025

NEW YORK, Nov. 11, 2025 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a federal securities class action lawsuit has been filed against DexCom, Inc. ("DexCom" or the "Company") (NASDAQ: DXCM) and certain of its officers for alleged violations of federal securities laws.

PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION

Class Period: July 26, 2024 – September 17, 2025 (inclusive)

The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and failed to disclose that:

Key Events:

What Are The Next Steps:

Investors who purchased or otherwise acquired DexCom securities during the Class Period may move the Court no later than December 26, 2025, to be appointed lead plaintiff.

Why Wolf Haldenstein Adler Freeman & Herz LLP? :

This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors.

We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP.

Contact:

Firm Website: Wolf Haldenstein Adler Freeman & Herz LLP

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

SOURCE Wolf Haldenstein Adler Freeman & Herz LLP